ERIC LUSTER: Open Payments
NPI 1003564154 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 37 payments from 9 companies in 2025. Trend: 2023 $339 · 2024 $1,068 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $208 |
| E.R. Squibb & Sons, L.L.C. | 7 | $168 |
| Lundbeck LLC | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Alkermes, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Theratechnologies Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
Products named: VRAYLAR, COBENFY, REXULTI, ARISTADA, FANAPT, INVEGA SUSTENNA, EGRIFTA, Qelbree.
Industry payments across AR — which companies pay providers there.
